Passage Bio, Inc. logo

Passage Bio, Inc.

ID: 7368282

Passage Bio, Inc is a Philadelphia-based biotechnology company developing genetics-based medicines.

3

Funding Rounds

$379.5m

Money raised

Overview

Passage Bio, Inc is a Philadelphia-based biotechnology company developing genetics-based medicines.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Passage Bio, Inc. has raised a total of $379.5m in funding over 3 rounds.

Key Insights:

  • Passage Bio, Inc. Venture round, January 21, 2021: $154m
  • Passage Bio, Inc. Series B round, September 4, 2019: $110m
  • Passage Bio, Inc. Series A round, February 15, 2019: $115.5m